PSC stands for primary sclerosing cholangitis, a chronic liver disease in which the bile ducts gradually become inflamed, scarred, and narrowed. Over time, this damage blocks the flow of bile, a digestive fluid the liver produces, leading to progressive liver injury. PSC is relatively rare, affecting roughly 12 per 100,000 people, and it most commonly appears in adults between the ages of 30 and 44.
What Happens to the Bile Ducts
Bile ducts are the network of small tubes that carry bile from the liver to the small intestine, where it helps digest fats. In PSC, the immune system triggers inflammation around these ducts. Over months and years, layers of scar tissue build up in a pattern pathologists describe as “onion skin” fibrosis, because the scarring wraps concentrically around each duct.
As the disease progresses, the scarring becomes so thick that it replaces the bile ducts entirely. Bile backs up into the liver, damaging liver cells and eventually leading to cirrhosis, the late-stage scarring that impairs liver function. The pace varies widely from person to person. Some people live with PSC for a decade or more before serious complications develop, while others progress faster.
Symptoms and How They Develop
PSC gets worse slowly, and many people have no symptoms at all when they’re first diagnosed. The disease is often discovered by accident, when routine blood work shows elevated liver enzymes. When symptoms do appear, they typically include itchy skin, fatigue, and pain in the upper right abdomen. Jaundice, a yellowish tint to the skin and the whites of the eyes, develops as bile flow becomes more obstructed.
A narrowed bile duct can also become infected. Signs of a bile duct infection include fever, chills, worsening jaundice, and sharp pain below the ribs on the right side. This is a more urgent situation that usually requires prompt treatment.
In later stages, when cirrhosis has set in, symptoms become more serious: fluid buildup in the abdomen (ascites), confusion from toxins the damaged liver can no longer filter, gastrointestinal bleeding from swollen veins in the esophagus or stomach, and significant weight loss.
The Strong Link to Inflammatory Bowel Disease
One of the most distinctive features of PSC is how closely it’s tied to inflammatory bowel disease. Roughly 60% to 80% of people with PSC also have IBD, and in about 70% of all PSC cases the specific form of IBD is ulcerative colitis. The reasons for this overlap aren’t fully understood, but both conditions involve an immune system that attacks the body’s own tissues, and they share genetic risk factors.
The connection runs in one direction more strongly than the other. While most PSC patients have IBD, only a small fraction of IBD patients develop PSC. If you’re diagnosed with PSC, your doctor will likely screen you for bowel inflammation even if you don’t have digestive symptoms, because the colitis in PSC patients can be unusually silent.
Cancer Risk and Other Complications
The complication that concerns doctors most is cholangiocarcinoma, or bile duct cancer. People with PSC carry a significantly higher risk of developing it compared to the general population. Studies estimate the 10-year risk at roughly 9% to 11%, though some reports place the lifetime risk as high as 36% depending on the population studied. Because the cancer is difficult to detect early and hard to treat once advanced, PSC patients are typically monitored with regular imaging and blood tests.
PSC also raises the risk of gallbladder problems, including gallstones and gallbladder polyps. Colorectal cancer risk is elevated too, particularly in people who have both PSC and ulcerative colitis. That combination calls for more frequent colonoscopies than either condition alone would require.
How PSC Is Managed
There is currently no medication that stops or reverses the scarring in PSC. Treatment focuses on managing symptoms and watching for complications. Itching can be treated with specific medications, and bile duct infections are treated with antibiotics. When a major bile duct becomes severely narrowed, a procedure called endoscopic dilation can stretch it open, sometimes with a small tube (stent) placed temporarily to keep it from closing again.
For people whose liver function deteriorates to the point of liver failure, or who develop bile duct cancer caught early enough, a liver transplant is the definitive treatment. Among all liver diseases that lead to transplant, PSC has some of the best long-term outcomes. Patient survival after transplant is about 94% at one year, 86% at five years, and 84% at ten years. The disease can recur in the new liver, but this doesn’t always lead to significant problems.
What Causes PSC
The exact cause remains unknown. PSC is considered an autoimmune or immune-mediated disease, meaning the body’s own immune system drives the damage. Genetic susceptibility plays a role: certain immune system genes are more common in PSC patients. Environmental triggers, possibly related to gut bacteria given the strong IBD connection, likely contribute as well. PSC is not caused by alcohol use, viral hepatitis, or any lifestyle factor a person can control.